Inducción e intubación en secuencia rápida en pacientes portadores de COVID-19 / Rapid sequence induction and intubation in Covid 19 carrier patients

Introducción: La inducción e intubación en secuencia rápida es un procedimiento en anestesiología de emergencia para controlar la vía aérea en pacientes graves e insertar un tubo en la tráquea en el menor tiempo posible. Originalmente, este proceder se indicaba en los casos de regurgitación y/o reflujo para atenuar y prevenir la aspiración del contenido gástrico. La técnica descrita y usada por primera vez en los años 1970 retomó su uso en el contexto de la pandemia Covid-19. Sin embargo, una técnica convencional de intubación de secuencia rápida no sería adecuada pues no evitaría la dispersión del virus desde la vía aérea del paciente hacia el entorno, con la posibilidad de contaminación del personal que la realice. Objetivo: Describir una técnica modificada de intubación de secuencia rápida en tiempos de Covid-19. Métodos: Se realizó una revisión de las primeras publicaciones con protocolos de esta técnica modificada. La búsqueda se realizó en base de datos como PubMed, Google Académico y Elsevier. Desarrollo: El aspecto más importante para el profesional que realice la técnica es lograr con éxito la maniobra y conservar la vida del paciente. En este sentido, debe ser el más experimentado y preparado para controlar el tiempo de cada una de las etapas en las que se divide. Conclusiones: En la enfermedad Covid-19 las situaciones clínicas son muy variantes por lo que los protocolos en la atención perioperatoria de los enfermos puede modificarse según exista nueva evidencia(AU)

Introduction: Rapid-sequence induction and intubation is an emergency anesthesiology procedure for airway control in critically ill patients and for inserting a tube into the trachea in the shortest possible time. Originally, this procedure was indicated in cases of regurgitation and/or reflux in order to attenuate and prevent aspiration of gastric contents. The technique, described and used for the first time in the 1970s, resumed its use in the context of the COVID-19 pandemic. However, a conventional rapid-sequence intubation technique would not be adequate as it would not prevent the virus spread from the patient's airway to the environment, with the possibility of contamination of the personnel performing it. Objective: To describe a modified rapid-sequence intubation technique in times of COVID-19. Methods: A review of the first publications with protocols of this modified technique was carried out. The search was carried out in databases such as PubMed, Google Scholar and Elsevier. Development: The most important aspect for the professional performing the technique is to achieve the maneuver successfully and preserve the life of the patient. In this respect, the physician must be the most experienced and prepared to control the time of each of the stages into which it is divided. Conclusions: In COVID-19, clinical situations are highly variable, a reason why protocols in the perioperative care of patients can be modified according to new evidence(AU)

Incidence of nausea and vomiting after fast-track anaesthesia for heart surgery

Abstract Objective: The aim of this study was to evaluate the incidence of postoperative nausea and vomiting (PONV) after fast-track cardiac anesthesia (FTCA) in the first 24-48 hours in the cardiac intensive care unit (CICU) after open-heart surgery, risk factors for PONV and its influence on CICU length of stay. Methods: A prospective observational study from January 1, 2013 to the end of December 2015 was performed in the CICU of a university hospital in the north of Jordan and Queen Alia Heart Institute, Amman, Jordan. Three hundred consecutive patients undergoing fast-track cardiac anesthesia in elective cardiac surgery were enrolled in the study. Nausea and vomiting were assessed after tracheal extubation, which was performed within 6-10 hours after surgery and during the first 24-48 hours in the CICU. Metoclopramide 10 mg intravenously was used as the initial antiemetic drug, but ondansetron 4 mg intravenously was also used as second line of management. Results: Nausea was reported in 46 (15.3%) patients, and vomiting in 31 (10.3%). Among females, 38 (33.9%) patients developed nausea and 20 (17.9%) developed vomiting. Among males, 8 (4.3%) patients developed nausea and 11 (5.9%) developed vomiting. Conclusion: PONV are relatively low after FTCA and the prophylactic administration of antiemetic drug before anesthesia or after extubation is not necessary.

Servicio de Anestesia Cardiovascular. Cardiocentro / Anesthetic management of arterial hipertensión

La hipertensión arterial eleva de forma inaceptable el riesgo en los pacientes sometidos a anestesia y se hace necesario un tratamiento meticuloso antes de la operación con el objetivo de controlarla. Se señalan los agentes de premedicación con los cuales se obtienen mejores resultados. Se realiza una revisión actualizada de las técnicas y agentes anestésicos empleados en el paciente hipertenso. Se expone el tratamiento médico preoperatorio actualizado, así como el tratamiento de las crisis de hipertensión arterial durante la anestesia(AU)

Arterial hypertension increases in an unacceptable way the risk in patients receiving anesthesia. Therefore, a meticulous treatment is necessary before surgery in order to control it. The premedication agents with which better results are obtained are stressed. An updated review of the techniques and anesthetics used in the hypertensive patient is made. The updated postoperative medical treatment as well as the treatment of the crisis of arterial hypertension during anesthesia are dealt with(AU)